I manage Global Business Development & Commercial Collaborations at ImmunoACT. My focus areas involve licensing, establishing and expanding commercial operations, health access initiatives and fundraising for prospective patients to receive CAR-T cell therapy, marketing initiatives to increase clinical/scientific awareness, and public relations. To that end I've driven the Go-to-Market execution for India's first market authorized CAR-T cell therapy across more than 70 treatment centres in India and its global outreach. Previously in generics and biosimilars, I have successfully contributed to building licensing partnerships in the EEA, LATAM, APAC, CIS, and MENA regions, along with sales of biosimilars in India. During that time, I contributed to novel biologics CDMO lead generation and business expansion in biologics in a hybrid role that involved project management of 5 novel biologics from their pre-IND process development to the clinic.I have a personal interest in the research areas of inherited metabolic diseases and in advanced therapeutics owing to my pre-clinical research background. My long-term goal is to bring breakthrough biological therapies in an equitably accessible manner to the masses. *Opinions & Analyses are solely my own, unless stated otherwise*